Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer
about
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseAspirin, cyclooxygenase inhibition and colorectal cancerMolecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldWhat is good for the circulation also lessens cancer riskMultiple roles of toll-like receptor 4 in colorectal cancerANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progressionClinical Profile of Cyclooxygenase-2 Inhibitors in Treating Non-Small Cell Lung Cancer: A Meta-Analysis of Nine Randomized Clinical Trials.Peroxisome proliferator-activated receptor δ promotes colonic inflammation and tumor growthCOX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.Aspirin use and survival after diagnosis of colorectal cancerRole of inflammation and inflammatory mediators in colorectal cancerHigh expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.Big opportunities for small molecules in immuno-oncology.Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women.Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinomaPrediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.Molecular Prognostic and Predictive Markers in Colorectal Cancer: Current StatusCyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.Targeting the tumor microenvironment: focus on angiogenesis.The role of COX-2 in intestinal inflammation and colorectal cancerEpigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancerCyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.PPARδ and PGE2 signaling pathways communicate and connect inflammation to colorectal cancerCyclical DNA Methylation and Histone Changes Are Induced by LPS to Activate COX-2 in Human Intestinal Epithelial Cells.Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients.The association between NSAID use and colorectal cancer mortality: results from the women's health initiative.Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.An inflammatory mediator, prostaglandin E2, in colorectal cancer.Molecular pathways involved in colorectal cancer: implications for disease behavior and preventionThe Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal CancerAurora-A expression is independently associated with chromosomal instability in colorectal cancer.Urinary PGE-M: a promising cancer biomarkerInflammation and cancer: how friendly is the relationship for cancer patients?Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.Cyclooxygenase-2 expression in animal cancers.Microbiota, disease, and back to health: a metastable journey.Genetic unraveling of colorectal cancer.
P2860
Q24289344-AF761D51-1310-4FF0-8D2A-C365EBCD6859Q24598813-96E0A1C1-7089-4547-A06F-592FC2129418Q24620628-A28F7EAB-615C-4E40-9068-151CF9CCE2EDQ26859261-DFE85873-9B10-43C3-A17E-073E1A73CF74Q27008380-488F98F9-5C5F-4211-9B76-E08A7463BF5BQ28248772-E87B724E-2E72-48B1-88F3-AF28C806DC12Q33430977-252EB752-4204-4845-A926-72F6A34B8008Q33627388-FA7FC0B6-3BD1-4C7C-8392-0E57F9423640Q33678308-D3E11C3B-5A78-4F0E-ABCE-BAEB141F0F34Q33708134-535CD0D0-2F54-41AC-B1E9-213662688F94Q33723499-4B2A8E84-ED4D-44C5-A32A-6071B9881434Q33764480-C6D2D5D3-74FB-4035-9C96-83D12AC6DD1CQ33957824-8C957536-F534-4913-9A60-5379E3947516Q33963953-8FCEE82F-5398-4D4C-9326-9A9FE7B235BFQ34051967-8407AB27-A048-4813-88E5-4AA1519D05D3Q34487689-7F8ABA39-5FEB-41F3-A564-70C7A650F9D4Q34621781-42AC49F6-85BF-4A72-B6DE-AE827C90D644Q34623382-782B6B3E-03CE-4A2F-A5B3-68032B0A68ADQ34629053-20AA4464-49DA-40E7-B581-27A59A999910Q34976621-D34BD1D2-2299-448D-9F73-388DA1E550AEQ35096604-B5FA31C3-5BF2-4B4A-A0D6-AAD855F36390Q35184806-0E7B5815-7750-41E0-8363-679A92B41B8BQ35234704-EB3F455F-2BA8-4CDD-8BB9-F6DFE581E9C4Q35881186-5D87E989-B7C7-4C3B-919B-D245D9A1FEA5Q35884306-76C82D45-8211-40A4-A773-35E3A4ECA247Q35963300-A9277EAB-60E5-4B15-8E5A-F17C55F1C2C0Q36038028-C9D39CF7-1FD7-447E-8F26-3C7A780FAEA8Q36081008-A0935E17-C01D-42CC-95CB-AA598DCA0E2DQ36385115-96019DDA-EE73-4FEC-A5E6-33FD29A1D561Q36604053-29FFF3B5-79F7-4886-893E-ABB75FB265A2Q36701908-DFD0F48E-BB23-433B-9CB6-15D86FF08D65Q37139174-548E5855-4DC5-4B78-B381-4E82D1B6FA96Q37148157-869B194C-06AC-4EE5-A32B-183EAAAAD1CAQ37165838-E13CBFF7-B56F-4D8D-A6DC-90B5A2AD6FC8Q37166867-453D9B5C-9404-46D8-B1C1-AB0B0CDC1737Q37316105-346AB430-BDBA-467B-B3F9-AC36336A7875Q37337699-467A03B2-BE8D-4DBB-A4C6-EFD7A4F18836Q37793667-4ABEE71E-1837-4958-9535-A599097C5707Q38016807-69C44299-F5AE-421C-AB46-8F6F4A101906Q38191462-214CA412-498F-48B3-B770-A79026C7C162
P2860
Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer
@en
Cyclooxygenase-2 expression is ...... oor prognosis in colon cancer.
@nl
type
label
Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer
@en
Cyclooxygenase-2 expression is ...... oor prognosis in colon cancer.
@nl
prefLabel
Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer
@en
Cyclooxygenase-2 expression is ...... oor prognosis in colon cancer.
@nl
P2093
P2860
P1476
Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer
@en
P2093
Aditi Hazra
Andrew T Chan
Gregory J Kirkner
Kaori Shima
Katsuhiko Nosho
Natsumi Irahara
Reiko Dehari
Shoko Kure
Shuji Ogino
P2860
P304
P356
10.1158/1078-0432.CCR-08-1841
P407
P577
2008-12-01T00:00:00Z